Explore the vast range of titles available.

\"\"The Americans will have no Center of Union among them, and no Common Interest to pursue, when the Power and Government of England are finally removed. Moreover, when the Intersections and Divisions of their Country by great Bays of the Sea, and by vast Rivers, Lakes, and Ridges of Mountains;-and above all, when those immense inland Regions, beyond the Back Settlements, which are still unexplored, are taken into the Account, they form the highest Probability that the Americans never can be united ... under any Species of Government whatever. Their Fate seems to be- A DISUNITED PEOPLE, till the End of Time.\" -Josiah Tucker (1781) \"What then is the American, this new man? ... He is an American, who, leaving behind him all his ancient prejudices and manners, receives new ones from the new mode of life he has embraced, the new government he obeys, and the new rank he holds.\"\"-- Provided by publisher.

The aims of this study were to investigate the effects of either hearing, vision or dual sensory impairment on depressive symptoms and to identify subgroups that are vulnerable and significantly affected. Data from the 2006-2014 Korean Longitudinal Study of Aging (KLoSA) were used and a total of 5832 individuals were included in this study. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES-D10) scale. Sensory impairment was assessed according to the levels of self-reported hearing or vision, which were categorised as either good (excellent, very good or good) or poor (fair or poor). The changes in hearing or vision from records of previous survey were investigated. Changes from good to poor, which indicates new onset, were defined as hearing impairment or vision impairment. Interactions of changes in hearing and vision were considered in the analysis. Dual sensory impairment was indicated when hearing impairment and vision impairment both developed at the same time. Demographic, socioeconomic and health-related factors were considered as potential confounders and were adjusted for in the generalised estimating equation model. Individuals with hearing impairment demonstrated significantly more severe depressive symptoms [β = 0.434, standard errors (s.e.) = 0.097, p < 0.001] than those who had good hearing. Those with vision impairment also showed significantly elevated depressive symptoms (β = 0.253, s.e. = 0.058, p < 0.001) than those with good vision. When the interactions between hearing and vision were considered, participants with dual sensory impairment showed significantly more severe depressive symptoms (β = 0.768, s.e. = 0.197, p < 0.001) than those with good hearing and vision. The effect of a single and dual sensory impairment on depressive symptoms was significant in both sexes and across age groups, except for vision impairment in male participants. Hearing, vision and dual sensory impairment are significantly associated with depressive symptoms. Our results suggest that treatment or rehabilitation of either hearing or vision impairment would help prevent depression.

While any dermal wound in an adult human, even if treated, will result in scarring (1), the ‘holy grail’ of wound healing is ‘scarless wound healing’: wound repair via the regeneration of functional, native tissue. Fibroblasts are critical in all three phases,playing a key role in the deposition of extracellular matrix (ECM) components, wound contraction and remodeling of new ECM. Since our previous review (3), recent work continues to show the striking heterogeneity of skin fibroblasts. Fibroblast heterogeneity across pathological wound healing states Human wound healing may be viewed as a spectrum, with typical scar formation representing the ‘normal’ phenotype;chronic wounds at one extreme and hyperproliferative scarring and even keloids at the other. Financial and competing interests disclosure MT Longaker is a co-founder of, has an equity position in, and serves on the board of Neodyne Biosciences, Inc., a startup company which developed a device to reduce mechanical tension on wounds to minimize post-operative scarring.The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

يفسح الواقع بالتدريج مجالا للخيالات الشبيهة بالأحلام والحكايات الخرافية داخل \"كسارة البندق\" التي تعد واحدة من أحسن القصص المؤلفة عن الكريسماس. ويتم من خلال هذه النسخة من \"السلسلة العالمية للروائع الأدبية\"-والتي يستعان فيها بالصور بشكل مبتكر-الكشف عن الخلفية التاريخية المبهرة التي تقوم عليها هذه الحكاية الرائعة. وقد أسهمت رسومات \"جيمس مايهو\" التي تتسم بالثراء في إثارة المعاني، إلى جانب إعادة الرواية بشكل مفعم بالحيوية لـ \"ديفيد كليمينت\" في إعادة كل ما كان يتمتع به النص الأصلي من طاقة وإثارة وخيال-الأمر الذي يجعل قصة \"كسارة البندق\" تتناسب مع كل الأعمار. إن الصور والحقائق التاريخية تضع القصة في سياق عصري ؛ لتسمح للقراء بالدخول كلية في عالم الحكاية الشبيه بالأحلام.

Analysis of circulating tumour DNA could stratify cancer risk in symptomatic patients. We aimed to evaluate the performance of a methylation-based multicancer early detection (MCED) diagnostic test in symptomatic patients referred from primary care. We did a multicentre, prospective, observational study at National Health Service (NHS) hospital sites in England and Wales. Participants aged 18 or older referred with non-specific symptoms or symptoms potentially due to gynaecological, lung, or upper or lower gastrointestinal cancers were included and gave a blood sample when they attended for urgent investigation. Participants were excluded if they had a history of or had received treatment for an invasive or haematological malignancy diagnosed within the preceding 3 years, were taking cytotoxic or demethylating agents that might interfere with the test, or had participated in another study of a GRAIL MCED test. Patients were followed until diagnostic resolution or up to 9 months. Cell-free DNA was isolated and the MCED test performed blinded to the clinical outcome. MCED predictions were compared with the diagnosis obtained by standard care to establish the primary outcomes of overall positive and negative predictive value, sensitivity, and specificity. Outcomes were assessed in participants with a valid MCED test result and diagnostic resolution. SYMPLIFY is registered with ISRCTN (ISRCTN10226380) and has completed follow-up at all sites. 6238 participants were recruited between July 7 and Nov 30, 2021, across 44 hospital sites. 387 were excluded due to staff being unable to draw blood, sample errors, participant withdrawal, or identification of ineligibility after enrolment. Of 5851 clinically evaluable participants, 376 had no MCED test result and 14 had no information as to final diagnosis, resulting in 5461 included in the final cohort for analysis with an evaluable MCED test result and diagnostic outcome (368 [6·7%] with a cancer diagnosis and 5093 [93·3%] without a cancer diagnosis). The median age of participants was 61·9 years (IQR 53·4–73·0), 3609 (66·1%) were female and 1852 (33·9%) were male. The MCED test detected a cancer signal in 323 cases, in whom 244 cancer was diagnosed, yielding a positive predictive value of 75·5% (95% CI 70·5–80·1), negative predictive value of 97·6% (97·1–98·0), sensitivity of 66·3% (61·2–71·1), and specificity of 98·4% (98·1–98·8). Sensitivity increased with increasing age and cancer stage, from 24·2% (95% CI 16·0–34·1) in stage I to 95·3% (88·5–98·7) in stage IV. For cases in which a cancer signal was detected among patients with cancer, the MCED test's prediction of the site of origin was accurate in 84·8% (95% CI 79·5–89·0) of cases. Sensitivity 80·4% (95% CI 66·1–90·6) and negative predictive value 99·1% (98·2–99·6) were highest for patients with symptoms mandating investigation for upper gastrointestinal cancer. This first large-scale prospective evaluation of an MCED diagnostic test in a symptomatic population demonstrates the feasibility of using an MCED test to assist clinicians with decisions regarding urgency and route of referral from primary care. Our data provide the basis for a prospective, interventional study in patients presenting to primary care with non-specific signs and symptoms. GRAIL Bio UK.

Background Depression shows different patterns depending on socioeconomic status (SES) and metabolic syndrome (MS). However, the nature of this association remains poorly understood. The aim of this study was to examine whether the combination of MS and lower SES was associated with the prevalence of depression, based on data from the Korea National Health and Nutrition Examination Survey (KNHANES). Methods Data were obtained from a cross-sectional study of 24,102 adults (> 19 years of age) who participated in the KNHANES during 2008–2013 and for whom MS and depression data were available. MS was defined using the diagnostic criteria of the modified National Cholesterol Education Program Adult Treatment Panel III. Measure of depression was ascertained from self-reports of physician diagnosis. Multiple logistic regression analysis was used to evaluate the association between depression and MS as well as SES (alone and in combination). Results Overall, 622 of the 24,102 subjects (2.6%) met the criteria for depression. The prevalence of depression was associated with MS, a lower high-density lipoprotein cholesterol level, an elevated triglyceride level, a lower education level, and a lower household income. Participants with MS and a low SES had a higher likelihood of depression than those without MS and a high SES (odds ratio [OR] = 4.180 for low education level and OR = 3.994 for low household income level). Conclusions This study suggests that the combination of SES and MS may play an important role in depression, which has implications for healthcare policy and depression management.

Follows Mickey and his friends on twelve adventures, as they learn to surf, go white-water rafting, and visit the amusement park.

Chronic myeloid leukaemia (CML) arises after transformation of a haemopoietic stem cell (HSC) by the protein-tyrosine kinase BCR–ABL. Direct inhibition of BCR–ABL kinase has revolutionized disease management, but fails to eradicate leukaemic stem cells (LSCs), which maintain CML. LSCs are independent of BCR–ABL for survival, providing a rationale for identifying and targeting kinase-independent pathways. Here we show—using proteomics, transcriptomics and network analyses—that in human LSCs, aberrantly expressed proteins, in both imatinib-responder and non-responder patients, are modulated in concert with p53 (also known as TP53) and c-MYC regulation. Perturbation of both p53 and c-MYC, and not BCR–ABL itself, leads to synergistic cell kill, differentiation, and near elimination of transplantable human LSCs in mice, while sparing normal HSCs. This unbiased systems approach targeting connected nodes exemplifies a novel precision medicine strategy providing evidence that LSCs can be eradicated. Leukaemic stem cells (LSCs) are responsible for BCR–ABL-driven chronic myeloid leukaemia relapse; here, p53 and MYC signalling networks are shown to regulate LSCs concurrently, and targeting both these pathways has a synergistic effect in managing the disease. Dual targeting of p53 and c-Myc pathways Tyrosine kinase inhibitors are a first-line therapy in patients with chronic myeloid leukaemia (CML), where they target the oncogenic BCR-ABL fusion gene. However, relapse inevitably occurs, probably driven by a drug-resistant population of leukaemic stem cells (LSCs). This study uncovers the concurrent involvement of p53 and Myc signalling networks in regulating LSCs. The authors demonstrate that genetic and/or pharmacological targeting of both the p53 and c-Myc pathways achieves more effective disease neutralization in mouse and human cell models of CML.